Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes

Listen as faculty review the signs symptoms laboratory histopathologic and image findings that lead to better diagnosis of uILD. Review treatment strategies for managing patients with uILD and hear expert perspectives on the clinical trial findings of emerging treatments.

Topics Include:

  • Appropriate Classification
  • Challenges With uILD Diagnosis Prognosis and Follow-up
  • Treatments: Evidence for and Against Corticosteroids Immunotherapies and Antifibrotics
  • Questions and Answers

Share

Program Content

Activities

  • Webcast
    Unclassifiable Interstitial Lung Disease: Update on Challenges and Successes
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 05, 2021

    Expires: August 04, 2022

Faculty

cover img faculity

Toby Maher, MD, PhD, FRCP

Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Southern California
Director of Interstitial Lung Disease
Division of Pulmonary, Critical Care, and Sleep Medicine
Keck Medicine of USC
Los Angeles, California

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group